Clinic of Neurology, University Medical Center Tuzla, Tuzla, Bosnia and Herzegovina.
Faculty of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.
Med Arch. 2020 Oct;74(5):368-373. doi: 10.5455/medarh.2020.74.368-373.
Multiple sclerosis (MS) is a chronic, inflammatory, (auto) immune disease of the central nervous system (CNS). Quality of life (QoL) refers to the perception of an individual's life in the context of the system of culture and values in which they live.
The aim of the study was to determine the distribution of cognitive disorders in people with MS.
The prospective study included 135 participants with MS and 50 healthy participants. Participants were divided into three groups: the first group consisted of 85 participants where the disease lasted longer than one year, the second group consisted of 50 participants with newly diagnosed MS, the third group consisted of 50 healthy participants. The instruments of clinical assessment were: Extended Disability Score in Multiple Sclerosis Patients, Mini Mental Status, Beck Depression Scale, and Quality of Life Scale (SF-36, Contemporary Health Survey).
The quality of life related to health is impaired in the physical, mental dimension and overall quality of life. In the first group of participants, 62% had mild depression, and in the second group 38% of participants, while more severe forms were recorded in 16% of participants in both groups. As depression increases, the quality of life decreases in all measured dimensions, which would mean that depression negatively affects the quality of life. The results of all dimensions as well as the overall quality of life score are worse with the increase in the degree of clinical disability, for both groups of study patients.
Quality of life is impaired in MS patients, and a higher degree of clinical disability and an increase in depressive disorder are predictors of deteriorating quality of life in MS patients.
多发性硬化症(MS)是一种慢性、炎症性、(自身)免疫性中枢神经系统(CNS)疾病。生活质量(QoL)是指个体在其所处文化和价值观体系中对生活的感知。
本研究旨在确定多发性硬化症患者认知障碍的分布情况。
本前瞻性研究纳入了 135 名多发性硬化症患者和 50 名健康对照者。参与者被分为三组:第一组由 85 名疾病持续时间超过一年的患者组成,第二组由 50 名新诊断为多发性硬化症的患者组成,第三组由 50 名健康对照者组成。临床评估的工具包括:多发性硬化症患者扩展残疾评分、简易精神状态检查、贝克抑郁量表和生活质量量表(SF-36、当代健康调查)。
与健康相关的生活质量在生理、心理维度和整体生活质量方面均受损。在第一组参与者中,62%有轻度抑郁,在第二组中,38%的参与者有抑郁,而在两组参与者中,更严重的形式分别记录在 16%的参与者中。随着抑郁程度的增加,所有测量维度的生活质量都下降,这意味着抑郁会对生活质量产生负面影响。随着临床残疾程度的增加,所有维度的结果以及整体生活质量评分都会变差,对于两组研究患者都是如此。
多发性硬化症患者的生活质量受损,临床残疾程度较高和抑郁障碍增加是多发性硬化症患者生活质量恶化的预测因素。